Table of Contents

company-logo

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase IIa clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.

Alterity Therapeutics Dividend Announcement

• Alterity Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Alterity Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Alterity Therapeutics Dividend History

Alterity Therapeutics Dividend Yield

Alterity Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Alterity Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Alterity Therapeutics Financial Ratios

P/E ratio-1.24
PEG ratio0.50
P/B ratio2.23
ROE-137.73%
Payout ratio0.00%
Current ratio3.54
Quick ratio3.54
Cash Ratio2.35

Alterity Therapeutics Dividend FAQ

Does Alterity Therapeutics stock pay dividends?
Alterity Therapeutics does not currently pay dividends to its shareholders.
Has Alterity Therapeutics ever paid a dividend?
No, Alterity Therapeutics has no a history of paying dividends to its shareholders. Alterity Therapeutics is not known for its dividend payments.
Why doesn't Alterity Therapeutics pay dividends?
There are several potential reasons why Alterity Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Alterity Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Alterity Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Alterity Therapeutics a dividend aristocrat?
Alterity Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Alterity Therapeutics a dividend king?
Alterity Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Alterity Therapeutics a dividend stock?
No, Alterity Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Alterity Therapeutics stocks?
To buy Alterity Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Alterity Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.